These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29152727)

  • 1. Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature.
    Bacik LC; Chung C
    Int J Dermatol; 2018 Jun; 57(6):627-634. PubMed ID: 29152727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).
    Poljak M; Šterbenc A; Lunar MM
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):987-999. PubMed ID: 29027811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus, cancer and vaccination.
    Heard I
    Curr Opin HIV AIDS; 2011 Jul; 6(4):297-302. PubMed ID: 21519247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus-related oropharyngeal cancer in the HIV-infected population.
    Wang CC; Palefsky JM
    Oral Dis; 2016 Apr; 22 Suppl 1():98-106. PubMed ID: 27109278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus, human immunodeficiency virus and immunosuppression.
    Denny LA; Franceschi S; de Sanjosé S; Heard I; Moscicki AB; Palefsky J
    Vaccine; 2012 Nov; 30 Suppl 5():F168-74. PubMed ID: 23199960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease.
    Mboumba Bouassa RS; Prazuck T; Lethu T; Jenabian MA; Meye JF; Bélec L
    Expert Rev Anti Infect Ther; 2017 Jun; 15(6):613-627. PubMed ID: 28440679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C; Roden RBS; Kirnbauer R
    Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus vaccination in HIV-infected women: need for increased coverage.
    Kojic EM; Rana AI; Cu-Uvin S
    Expert Rev Vaccines; 2016; 15(1):105-17. PubMed ID: 26599305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
    Brotherton JML; Tabrizi SN; Phillips S; Pyman J; Cornall AM; Lambie N; Anderson L; Cummings M; Payton D; Scurry JP; Newman M; Sharma R; Saville M; Garland SM
    Int J Cancer; 2017 Oct; 141(8):1576-1584. PubMed ID: 28677147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
    Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
    Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
    Poljak M
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
    Guo T; Eisele DW; Fakhry C
    Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cervical cancer: Current situation and management in Morocco].
    Belglaiaa E; Mougin C
    Bull Cancer; 2019 Nov; 106(11):1008-1022. PubMed ID: 31606139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papilloma virus-related premalignant and malignant lesions of the cervix and anogenital tract in immunocompromised women.
    Wielgos AA; Pietrzak B
    Ginekol Pol; 2020; 91(1):32-37. PubMed ID: 32039466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus vaccines and anal carcinoma.
    Franceschi S; De Vuyst H
    Curr Opin HIV AIDS; 2009 Jan; 4(1):57-63. PubMed ID: 19339940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can male vaccination reduce the burden of human papillomavirus-related disease in the United States?
    Low GM; Attiga YS; Garg G; Schlegal R; Gallicano GI
    Viral Immunol; 2012 Jun; 25(3):174-86. PubMed ID: 22691099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Papillomavirus-Related Cancers.
    Li Y; Xu C
    Adv Exp Med Biol; 2017; 1018():23-34. PubMed ID: 29052130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
    Hall MT; Smith MA; Simms KT; Barnabas R; Murray JM; Canfell K
    Int J Cancer; 2021 Jul; 149(2):297-306. PubMed ID: 33634857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.